Looking beyond 28-day all-cause mortality

AUTOR(ES)

Rubenfeld, Gordon

FONTE

BioMed Central

RESUMO

A growing body of evidence indicates that survivors of intensive care have an impaired quality of life. It is not entirely clear from the available literature whether this impairment is a complication of critical illness or a complication of therapy. There is little evidence to guide physicians to treatments in the intensive care unit that will minimize the effects of critical illness on these sequelae. Although the study by Rublee and colleagues in this issue of Critical Care provides little clinically useful information about the effects of antithrombin III on quality of life, it provides some insight into the challenges that investigators will encounter as we try to incorporate these outcomes into studies of critical illness.

Documentos Relacionados

• All-Cause and Cause-Specific Mortality Among Men Released From State Prison, 1980–2005
• Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?
• The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
• Coffee Consumption and Risk of Cardiovascular Diseases and All-Cause Mortality Among Men With Type 2 Diabetes
• Performance of a Hematological Scoring System in Predicting All-Cause Mortality in Patients with Acute Myocardial Infarction